Physician profile
Devora S Cohen
NPI 1568498400
$1,781.23
in general payments reported to CMS, 2019-2025
14 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $257 · 2021: $23.58 · 2022: $135 · 2023: $306 · 2024: $274 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $616.92 | 2019-2025 | Evenity |
| Novo Nordisk INC | $474.23 | 2020-2024 | Wegovy |
| Lilly USA, LLC | $175.08 | 2019-2021 | |
| Gilead Sciences, INC. | $123.74 | 2023 | Descovy |
| Recordati_rare_diseases_inc. | $103.57 | 2025 | Isturisa |
| Pfizer INC. | $93.86 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.45 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $33.22 | 2024 | Fasenra |
| Vanda Pharmaceuticals INC. | $32.38 | 2019 | |
| Scilex Pharmaceuticals INC. | $24.35 | 2023 | Ztlido |
| Janssen Scientific Affairs, LLC | $18.04 | 2020 | |
| Shire North American Group INC | $17.00 | 2019 | |
| Exact Sciences Corporation | $14.47 | 2025 | The Cologuard Plus Collection Kit |
| Endo Pharmaceuticals INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devora Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.